San Francisco, CA4 Active Studies

ALS Clinical Trials in San Francisco, CA

Find 4 actively recruiting als clinical trials in San Francisco, CA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
382
Enrolling

Recruiting ALS Studies in San Francisco

RecruitingSan Francisco, CANCT06643481

A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)

This is a multicenter, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early-stage ALS (within 2 years of...

225 participants
Novartis Pharmaceuticals
View Study Details
RecruitingSan Francisco, CANCT06527222

A Study of Ranolazine in ALS

The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS....

72 participants
Swathy Chandrashekhar, MBBS
View Study Details
RecruitingSan Francisco, CANCT05395624

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

This is a Phase 1/2 study to evaluate the safety and tolerability of 18F-OP-801 in subjects with ALS, AD, MS, PD and age-matched HVs. 18F-OP-801 is intended as a biomarker for PET imaging of activated...

65 participants
Ashvattha Therapeutics, Inc.
View Study Details
RecruitingSan Francisco, CANCT06100276

Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)

This is the study of AMT-162 in Participants with SOD1-ALS and is designed to evaluate the safety, tolerability, and exploratory efficacy of intrathecally administered gene therapy AMT-162. AMT-162-00...

20 participants
UniQure Biopharma B.V.
View Study Details

About ALS Clinical Trials in San Francisco

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons controlling voluntary muscle movement. Also known as Lou Gehrig's disease, it leads to increasing paralysis. Research is actively pursuing disease-modifying treatments and gene therapies.

There are currently 4 als clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 382 participants. Research is being sponsored by Novartis Pharmaceuticals, Swathy Chandrashekhar, MBBS, Ashvattha Therapeutics, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

ALS Clinical Trials in San Francisco — FAQ

Are there als clinical trials in San Francisco?

Yes, there are 4 als clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What als treatments are being tested?

The 4 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for als.

Data updated March 2, 2026 from ClinicalTrials.gov